Literature DB >> 371652

The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease.

I Keber, M Jerse, D Keber, M Stegnar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 371652      PMCID： PMC1429501          DOI： 10.1111/j.1365-2125.1979.tb00934.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  20 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol.

Authors:  W H Frishman; B Weksler; J P Christodoulou; C Smithen; T Killip
Journal:  Circulation       Date:  1974-11       Impact factor: 29.690

Review 3.  Emerging concepts of platelet function.

Authors:  D Deykin
Journal:  N Engl J Med       Date:  1974-01-17       Impact factor: 91.245

4.  Platelet function studies in coronary artery disease.

Authors:  P P Steele; H S Weily; H Davies; E Genton
Journal:  Circulation       Date:  1973-12       Impact factor: 29.690

5.  Beta-adrenergic receptors in human platelets.

Authors:  Y H Abdulla
Journal:  J Atheroscler Res       Date:  1969 Mar-Apr

6.  Aspirin selectively inhibits prostaglandin production in human platelets.

Authors:  J B Smith; A L Willis
Journal:  Nat New Biol       Date:  1971-06-23

7.  Effects "in vitro" of some cardiovascular drugs and other agents on human platelet aggregation.

Authors:  G Sacchetti; D Bellani; C Montanari; A Gibelli
Journal:  Thromb Diath Haemorrh       Date:  1973-02-28

8.  Effect of propranolol on platelet function.

Authors:  B B Weksler; M Gillick; J Pink
Journal:  Blood       Date:  1977-02       Impact factor: 22.113

9.  Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.

Authors: 
Journal:  Br Med J       Date:  1977-08-13

10.  Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205
View more
  6 in total

1.  Antiplatelet effects of oral diltiazem, propranolol, and their combination.

Authors:  M E Ring; J J Corrigan; P E Fenster
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

2.  Effect of propranolol on platelet signal transduction.

Authors:  D Dash; K Rao
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

3.  Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.

Authors:  A Markel; J G Brook; Y Levy; M Aviram; M B Youdim
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

4.  Effects of propranolol in vitro and in vivo on platelet function and thromboxane formation in normal volunteers.

Authors:  W Siess; R Lorenz; P Roth; P C Weber
Journal:  Agents Actions       Date:  1983-02

5.  Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.

Authors:  H J Jürgensen; J Dalsgaard-Nielsen; E Kjøller; J Gormsen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Modulation of P-selection and platelet aggregation in chronic periodontitis: A clinical study.

Authors:  Ramesh Perumal; Maheashwari Rajendran; Malathi Krishnamurthy; Kiran Kumar Ganji; Sunil Dattuji Pendor
Journal:  J Indian Soc Periodontol       Date:  2014-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.